Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lougheed

Showing results (371-380 of 446) with videos related to

Pageof 45
Sort By:
Cancer Immunology, Immunotherapy : CII|February 14, 2019
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimusInge M Werter, Charlotte M Huijts, Sinéad M Lougheed, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
Building skeletally diverse architectures on the Indoline Scaffold: the discovery of a chemical probe of focal adhesion kinase signaling networksMichael Prakesch, Krikor Bijian, Valérie Campagna-Slater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2018
Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR TrialBernard Escudier, Thomas Powles, Robert J Motzer, et al.
Cancer Research|October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinasesFawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Clinical Immunology (Orlando, Fla.)|June 24, 2010
Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramideHetty J Bontkes, María Moreno, Basav Hangalapura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiationClaudia C Sombroek, Anita G M Stam, Allan J Masterson, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell lineSaskia J A M Santegoets, Marco W J Schreurs, Allan J Masterson, et al.
Journal of Combinatorial Chemistry|January 17, 2009
Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathwaysRajamohan R Poondra, N Niranjan Kumar, Krikor Bijian, et al.
BMC Medical Genomics|November 29, 2019
Return of genetic and genomic research findings: experience of a pediatric biorepositoryTanya Papaz, Eriskay Liston, Laura Zahavich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8<sup>+</sup> T Cells and Elevated β-Catenin Activation Compared with Squamous Cell CarcinomaJossie Rotman, A Marijne Heeren, Awa A Gassama, et al.
Pageof 45

Showing results (371-380 of 446) with videos related to

Sort By:
Pageof 45
Cancer Immunology, Immunotherapy : CII|February 14, 2019
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimusInge M Werter, Charlotte M Huijts, Sinéad M Lougheed, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
Building skeletally diverse architectures on the Indoline Scaffold: the discovery of a chemical probe of focal adhesion kinase signaling networksMichael Prakesch, Krikor Bijian, Valérie Campagna-Slater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2018
Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR TrialBernard Escudier, Thomas Powles, Robert J Motzer, et al.
Cancer Research|October 8, 2009
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinasesFawn Qian, Stefan Engst, Kyoko Yamaguchi, et al.
Clinical Immunology (Orlando, Fla.)|June 24, 2010
Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramideHetty J Bontkes, María Moreno, Basav Hangalapura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiationClaudia C Sombroek, Anita G M Stam, Allan J Masterson, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell lineSaskia J A M Santegoets, Marco W J Schreurs, Allan J Masterson, et al.
Journal of Combinatorial Chemistry|January 17, 2009
Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathwaysRajamohan R Poondra, N Niranjan Kumar, Krikor Bijian, et al.
BMC Medical Genomics|November 29, 2019
Return of genetic and genomic research findings: experience of a pediatric biorepositoryTanya Papaz, Eriskay Liston, Laura Zahavich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8<sup>+</sup> T Cells and Elevated β-Catenin Activation Compared with Squamous Cell CarcinomaJossie Rotman, A Marijne Heeren, Awa A Gassama, et al.
Pageof 45